Dow Up 0.76% Nasdaq Up 0.69%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM
1.51 Up 0.04(2.72%) Oct 24, 4:00PM EDT
Prev Close:1.47
Open:1.48
Bid:N/A
Ask:3.20 x 800
1y Target Est:4.17
Beta:-0.31
Earnings Date:Dec 8 - Dec 12 (Est.)
Day's Range:1.46 - 1.53
52wk Range:1.16 - 3.18
Volume:885,218
Avg Vol (3m):1,063,880
Market Cap:271.05M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PPHM

Comparison

Symbol% ChgMkt Cap
PPHMUp 2.72%271.05M
AMGNUp 0.01%111.86B
NVSUp 1.02%218.72B
RHHBYDown 0.19%248.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Apr-15) :-0.30
Quarterly EPS Est (Oct-14) :-0.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the research and development of novel monoclonal antibodies for the treatment and diagnosis of cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback